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Abstract We examined the serum levels of IL-6, IL-8,
TNF, IL-6R, TNF-R1, and CRP and the dynamics of
changes in these levels according to age. The study
included healthy individuals of 20–90 years of age. Par-
ticipants were divided into subgroups based on their decade
of life, and into subgroups of C65 or\65 years. Serum
cytokine levels were assayed by ELISA, and CRP using an
immunoturbidimetric method. Serum CRP levels were
within the normal range for all subgroups. The 60- to
70-year age group showed higher CRP than the 20- to 30-
(p = 0.003), 30- to 40- (p = 0.009), and 40- to 50-
(p = 0.030) year age groups. Serum cytokine levels were
low. It was greater in the 60- to 70-year age group than in
the 20- to 30- (p = 0.008) and 30- to 40- (p = 0.040) year
groups, and was greater in the 70- to 90-year group than the
20- to 30-year group (p = 0.043). Serum TNF-R1 level in
the 70- to 90-year group was greater than in all other age
groups (p = 0.000 for all comparisons). Other measured
parameters did not differ between groups. Serum levels of
IL-6, CRP, and TNF-R1 were greater in participants C65
than\65 years of age. Healthy older people showed low
serum levels of CRP and pro-inflammatory cytokines, but
higher than in younger population. Therefore, the adjust-
ment of normal ranges in the elderly should be considered.
Serum levels of pro-inflammatory cytokines elevated
beyond normal ranges indicate particular diseases.
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Introduction
Some studies show aging to be associated with a state of
chronic low-grade inflammation and increased serum
levels of inflammatory markers, including interleukin (IL)-
6, C-reactive protein (CRP), and tumor necrosis factor
(TNF) process that has been referred to as ‘‘inflammaging’’
(Michaud et al. 2013). Despite many clinical trials, the
mechanism behind these increases has not yet been fully
understood. However, it is proposed that the higher
inflammatory marker levels are related to increased volume
of adipose tissue (especially, visceral), decline of sex
hormones, and increased oxidative damage—all of which
are common in elderly individuals (Singh and Newman
2011). A chronic state of inflammation may have detri-
mental consequences, and thus the cause of inflammaging
is of great diagnostic and therapeutic importance.
Increased levels of inflammatory markers are generally
associated with age-related diseases, including cardiovas-
cular diseases, increased insulin resistance, and cancer
(Reuter et al. 2010; Singh and Newman 2011). Low-grade
inflammation is also involved in the mechanism underlying
age-related sarcopenia, neurodegenerative disorders, and
cognitive deficit (Michaud et al. 2013; Trollor et al. 2012).
IL-6 and CRP are both associated with mortality risk, and
IL-6 and TNF are both markers of frailty (Michaud et al.
2013; Varadhan et al. 2014). It remains unclear whether
increased serum levels of particular cytokines are direct
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causes of adverse effects and of the above-mentioned dis-
eases or, conversely, are the result of existing diseases.
The present study aimed to assess the serum levels of
pro-inflammatory cytokines (IL-6, IL-8, and TNF), the IL-
6 and TNF receptors (IL-6R and TNF-R1, respectively),
and CRP among healthy individuals aged 20–90 years, and
to trace the dynamics of changes in these concentrations
according to age in the absence of any co-morbidities.
Materials and Methods
The study included a total of 180 healthy individuals
between 20 and 90 years of age (mean age 49 ± 18 years),
recruited from their neighborhood, workplaces, nursing
homes, and retirement homes. These participants included
94 women and 86 men. None had any chronic diseases in
their medical history (including diabetes), and none of the
study participants took any medications. All results of
standard biochemical analysis were within the reference
value ranges, and all participants showed normal blood
pressure and BMI values. Table 1 presents the character-
istics of the study participants. Every person enrolled into
the study gave their written and informed consent to par-
ticipate, and the study was approved by the Bioethics
Committee of the Medical University of Warsaw (No. KB/
10/2010).
To analyze major laboratory parameters, whole blood
samples (2 mL) were drawn in polypropylene tubes and
allowed to clot for 30 min before centrifugation. Serum
was obtained by centrifugation for 10 min at approxi-
mately 10009g. The samples were stored at -80 C prior
to analysis.
Serum cytokine concentrations were determined by
enzyme-linked immunosorbent assays (ELISA) using kits
from R&D Systems (Minneapolis, Minnesota, USA).
Absorbance readings at 450 and 540 nm were taken using a
camera to read a spectrophotometric microplate (Biotek
Power Wave XS). CRP was measured via an immunotur-
bidimetric assay that uses reinforced latex particles (CRPLX
C-reactive Protein Latex kit; Roche Diagnostics, Indi-
anapolis, Indiana, USA) and a Cobas turbidimetric analyzer.
To assess kidney function, serum levels of cystatin C were
determined using a particle-enhanced immunonephelomet-
ric diagnostic assay (Siemens N Latex Cystatin C; Siemens,
Erlangen, Germany). The test was performed using a BN
ProSpec nephelometer (Siemens, Erlangen, Germany) fol-
lowing the manufacturer’s protocol.
Statistical Analysis
Mean values in the individual age groups were compared
using analysis of variance (ANOVA) methods, specifically
Tukey’s HSD test. The mean values for the two age groups
(C65 and\65 years) were compared using Tukey’s HSD
test and Welch’s t test. For each investigated parameter,
both tests gave the same results.
The correlations between pairs of parameters were
studied using linear regression analysis. A linear model
was fitted for each pair of parameters, on which two sta-
tistical tests of independence were performed: the
Student’s t test and the F test. The null hypothesis that the
variables were independent was rejected if the p value
was\0.05 for each test. The results of the two tests always
agreed. All computations were performed in R.
Results
To trace the dynamics of changes in serum levels of the
investigated cytokines with age, we divided the participants
into subgroups based on the decade of life (Table 2).
Several parameters significantly differed between age
groups. The 60- to 70-year age group showed significantly
greater mean CRP levels compared to the 20- to 30-
(p = 0.003), 30- to 40- (p = 0.009), and 40- to 50-
(p = 0.030) year age groups. The 60- to 70-year age group
also showed significantly greater mean IL-6 levels
Table 1 Characteristics of study participants stratified by age
Biomarkers (units) Under 65 years of




Weight (kg) 74.72 ± 16.24 73.51 ± 11.29
BMI 24.97 ± 3.94 26.30 ± 2.87
RBC (T/L) 4.82 ± 0.39 4.75 ± 0.40
HGB (g/L) 143.39 ± 12.65 141.46 ± 12.83
HCT (L/L) 0.43 ± 0.03 0.43 ± 0.03
WBC (G/L) 6.16 ± 1.43 6.50 ± 1.48
PLT (G/L) 252.87 ± 56.30 230.85 ± 58.42
Bilirubin (mg/dL) 0.68 ± 0.34 0.65 ± 0.20
Creatinine (mg/L) 0.92 ± 0.17 1.04 ± 0.28
eGFR CKD-EPI (mL/min) 90.16 ± 16.36 64.94 ± 15.18
Cystatin C (mg/L) 0.66 ± 0.10 0.81 ± 0.19
Urine pH 5.84 ± 0.64 5.81 ± 0.69
Glucose (mg/dL) 89.23 ± 10.35 97.44 ± 13.44
ALT (U/L) 28.33 ± 17.86 21.33 ± 7.65
AST 21.30 ± 8.09 22.03 ± 5.29
Cholesterol (mg/dL) 215.85 ± 44.87 201.56 ± 46.44
eGFR CKD-EPI (estimated glomerular filtration rate—according to
CKD-EPI formula)
BMI body mass index, RBC red blood cells, HGB hemoglobin, HCT
hematocrit, WBC white blood cells, PLT platelets, ALT alanine
transaminase, AST aspartate transaminase
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compared to the 20- to 30- (p = 0.008) and 30- to 40-
(p = 0.040) year age groups. IL-6 levels also significantly
differed between the 70- to 90- and 20- to 30-year age
groups (p = 0.043). The mean TNF-R1 concentration for
the 70- to 90-year age group was significantly greater
compared to all other age groups (p = 0.000 for all com-
parisons). The levels of IL-6R, IL-8, and TNF showed no
significant differences between age groups.
To detect potential differences in serum levels of the
investigated cytokines between the young and elderly, we
also divided the participants into two subgroups of C65 -
years of age and\65 years of age (Table 3).
Table 4 presents the correlation between the investi-
gated cytokines and the serum level of cystatin.
Discussion
Immune system function generally declines with aging and
is called immunosenescence. Immunosenescence is based
upon three theories: the autoimmune theory based on the
decreased ability to recognize between invaders and nor-
mal tissues, the immune deficiency theory based on the
diminished effectiveness of the immune system, and the
immune dysregulation theory based on the disruption of the
regulation between multiple components of the immune
system. Immunosenescence is a complex process, accom-
panied by some changes, for instance compromised
function in several cells including lymphocytes (naı¨ve,
effector, and memory), regulatory T and B cells,
monocytes, neutrophils, and NK cells, as reflected by
increased susceptibility to infectious diseases, altered
response to vaccination, increased prevalence of particular
diseases, and chronic pro-inflammatory states connected
with non-communicable diseases—including cardiovascu-
lar and neurodegenerative diseases, diabetes, declining
cognitive function, and frailty. Immunosenescence affects
individuals to a different extent, mainly because the dys-
function of the immune system is influenced by genetic and
environmental factors. Inflammatory response is an innate
defense, which is less affected by age than adaptive
response. (Bueno et al. 2014; Castelo-Branco and Soveral
2014; Franceschi et al. 2000; Yao and Moorman 2013).
Many investigators have reported that aging is associated
with increased levels of pro-inflammatory cytokines,
including IL-6, TNF, CRP, and TNF-R1 (Singh and
Newman 2011; Varadhan et al. 2014). These cytokines are
involved in the pathogenesis of many diseases, mainly
cardiovascular diseases, diabetes, and atherosclerosis
(Castelo-Branco and Soveral 2014). These cytokines are
also predictors of mortality, with low inflammatory marker
levels associated with better survival (Giovannini et al.
2011). However, it remains unclear whether the above-
mentioned non-communicable diseases are the cause of
pro-inflammatory state or are the reason of it.
In the present study, we assessed the serum levels of
CRP and particular cytokines in healthy aging.
First, we analyzed the serum levels of CRP, IL-6, IL-8,
TNF, IL-6R, and TNF-R1 in healthy individuals aged
20–90 years, stratified by different decades of life. We then
Table 2 Serum levels of CRP, IL-6, IL-6R, IL-8, TNF, and TNF R1 stratified by age




















































































Mean CRP levels in the 60- to 70-year age group was significantly greater compared to the 20- to 30- (p = 0.003), 30- to 40- (p = 0.009), and
40- to 50- (p = 0.030) year age groups. Mean IL-6 levels in the 60- to 70-year age group was significantly greater compared to the 20- to 30-
(p = 0.008) and 30- to 40- (p = 0.040) year age groups; it also significantly differed between the 70- to 90- and 20- to 30-year age groups
(p = 0.043). The mean TNF-R1 concentration for the 70- to 90-year age group was significantly greater compared to all other age groups
(p = 0.000 for all comparisons). The levels of IL-6R, IL-8, and TNF showed no significant differences between age groups
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analyzed these data into two subgroups: participants C65
and\65 years of age. With advanced age, we detected
slight increases of CRP and some cytokines. We also
confirmed the increases of IL-6, CRP, and TNF-R1 in
healthy individuals aged over 65 years compared to
younger participants. No statistically significant difference
was found in TNF levels, but there was a clear trend of
increase with age. However, despite the observed increases
with age, serum levels of the investigated cytokines were
generally low in all age groups. There are currently no
clinical thresholds for cytokines, including IL-6, but the
Whitehall II study proposed that an IL-6 serum level
of[2 ng/L is considered high (Akbaraly et al. 2013). In
our present group of participants above 65 years of age, the
average IL-6 serum level was below this limit. The higher
age group also had serum CRP levels within the normal
range of 0.2–3.0 mg/L according to the current edition of
Harrisson’s Principles of Internal Medicine (Kratz et al.
2012).
The presently obtained results do not contradict the
previous findings, indicating that chronic inflammatory
states contribute to disabilities and diseases of aging
(Guarner and Rubio-Ruiz 2014; Singh and Newman 2011).
Many people above 65 years of age suffer from various
diseases, with an over 70 % prevalence of multiple chronic
conditions in elderly populations (Bahler et al. 2015). The
group enrolled in the present study comprised a smaller
proportion of disease-free seniors. Age is an independent
risk factor for metabolic syndrome, diabetes, and cardio-
vascular diseases (Tereshina 2009). Multiple morbidities
could share common mechanisms, such as telomere
shortening, activation of mTOR signaling, impaired
autophagy, mitochondrial dysfunction, stem cell exhaus-
tion, abnormal miRNA profiles, or epigenetic changes.
Immunosenescence also belongs to this milieu (Barnes
2015). It is also possible that a particular abnormality could
trigger the production of pro-inflammatory cytokines,
which could then act as an independent risk factor for other
diseases (Ferrucci et al. 2005). The results of our investi-
gation conducted in healthy seniors do not clearly confirm
the inflammatory state; however, the need to adjust
Table 3 Serum levels of CRP, IL-6, Il-6R. IL-8, TNF, and TNF-R1
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Table 4 Correlations between the investigated cytokines and kidney function estimated by cystatin level with the measured concentrations of
CRP, IL-6, IL-6R, IL-8, TNF, and TNF-R1
CRP (mg/L) IL-6 (pg/mL) IL-6R (ng/mL) IL-8 (pg/mL) TNF (pg/mL) TNF-R1 (ng/mL)




NS NS NS p = 0.0000
R = 0.5258






NS NS p = 0.0000
R = 0.4965
CRP (mg/L) p = 0.0008
R = 0.2494
NS NS NS p = 0.0044
R = 0.2135
IL-6 (pg/mL) p = 0.0008
R = 0.2494
NS p = 0.0000
R = 0.3734
NS p = 0.0001
R = 0.2900
IL-6 R (ng/mL) NS NS NS NS p = 0.0072
R = 0.2124
IL-8 (pg/mL) NS p = 0.0000
R = 0.3734
NS NS NS
TNF (pg/mL) NS NS NS NS NS
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‘‘normal ranges’’ of CRP and pro-inflammatory cytokines
for the elderly population should be considered. The pop-
ulation differences should also be taken into account, due
to regional differences in cytokine genotype and poly-
morphism (Capurso et al. 2004). Also, diet is believed to
have a major influence on inflammatory signaling. It could
regulate the metabolic pathways and bioenergetics that can
be translated into stable epigenetic pattern of gene
expression (Szarc vel Szic et al. 2015).
Our results are in line with the results reported by Fer-
rucci et al. (2005), who stated that at least part of the ‘‘pro-
inflammatory state’’ in older persons is related to the
associated high prevalence of cardiovascular risk factors
and morbidity—not to age exclusively and with those
reported by Akbaraly et al. (2013). They found that only
high serum IL-6 levels (e.g., C2.0 ng/L) halved the odds of
successful aging (free of major chronic diseases and with
optimal physical, mental, and cognitive function) com-
pared with lower IL-6 levels. These results were unchanged
when the IL-6 levels were replaced with CRP levels in
regression analysis, or when obese participants were
excluded from analysis. Conversely, low serum levels of
IL-6 and CRP were connected with successful aging (Ak-
baraly et al. 2013).
Our present results showed relatively high standard
deviations, indicating large inter-individuals differences.
There may be complex reasons for the observed slight
increases of particular cytokines. In former centuries, the
human lifespan averaged 50 years, while it is now
80–100 years. This longer lifespan is associated with a
greater antigenic burden and greater lifelong antigenic
stress associated with continuous and unavoidable expo-
sure to various antigens, viruses, and bacteria, as well as
food and self-molecules (Franceschi et al. 2000). This sit-
uation could lead to a well-known reduction of naı¨ve T
cells and accumulation of effector T and memory cells, as
well as up-regulation of innate immunological defense,
connected with the slight increase in pro-inflammatory
cytokines (Castelo-Branco and Soveral 2014). The increase
in serum levels of pro-inflammatory cytokines and CRP
could also result from the decline in kidney function that is
observed with age. Supporting this theory, we found that
CRP, IL-6, IL-6R, and TNF-R1 levels were significantly
positively correlated with serum levels of the renal function
marker cystatin (Carbonnel et al. 2008).
Interestingly, the serum levels of IL-6, IL-8, and CRP
tended to decrease in the subgroup of 70–90 years of age;
however, the levels in this group did not significantly differ
from those in the subgroup aged 60–70 years. Inflamma-
tory cytokines and chemokines—including IL-6, IL-8, and
TNF—are products of the classical pro-inflammatory TLR
signaling pathway (Fraza˜o et al. 2013). According to the
results obtained by van Duin et al. (2007), older adults have
impaired responses to monocyte TLR1/2-specific stimula-
tion, with decreased TNF, IL-6, and IL-8 production
observed in older adults when compared with younger
ones.
Our results also showed that the patterns of changes with
aging differed among the various cytokine serum levels.
IL-6 increased slightly with age, while IL-8 did not. This is
in line with previously reported results. IL-8 is one of the
most important chemokines responsible for recruiting cir-
culating neutrophils to a site of infection, e.g., chemotaxis,
which is probably not affected by age (Castelo-Branco and
Soveral 2014; Franceschi et al. 2000). However, some data
indicate that aging is accompanied by reduced expression
of Toll-like receptor (TLR)1 in polymorphonuclear
leukocytes. Qian et al. (2014) reported that in older adults,
stimulation through TLR1 leads to lower IL-8 production.
In conclusion, here we show that healthy elderly indi-
viduals show low serum levels of CRP and pro-inflammatory
cytokines, but higher when compared to the younger popu-
lation. Therefore, the definition of normal ranges in the
elderly should be considered. Elevated serum levels of pro-
inflammatory cytokines above normal ranges indicate the
coexistence of diagnosed or undiagnosed disease.
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